The United States Adult Vaccine Market is projected to soar to US$ 11.10 billion by 2033, up from US$ 6.55 billion in 2024, ...
In addition to the flu vaccine, the recently updated COVID-19 vaccine and the RSV vaccine are available, as well as vaccines against other illnesses.
Phase 2 clinical study titled ‘A Phase 2, Randomized, Double-Blind, Active-Controlled, Dose-Finding Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 in Healthy Infants ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback